Generics lower U.S. drug spending despite other rising costs

08/8/2007 | NYTimes.com

Increasing public acceptance of generic drugs has slowed the overall U.S. spending on drugs despite an aging population and introduction of expensive new drugs. Analysts expect the next five years to be the golden era for generic drugs, with many generics coming on the market to compete with brand-name drugs losing their patent protection.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT